These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10785985)

  • 41. Using clinical guidelines to assess the potential value of laboratory medicine in clinical decision-making.
    Hicks AJ; Carwardine ZL; Hallworth MJ; Kilpatrick ES
    Biochem Med (Zagreb); 2021 Feb; 31(1):010703. PubMed ID: 33380890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid trafficking in cardiovascular disease.
    Sposito AC; Zimetti F; Barreto J; Zanotti I
    Adv Clin Chem; 2019; 92():105-140. PubMed ID: 31472752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid Profile Consultation.
    Bachorik PS
    MD Comput; 1987; 4(4):50-2. PubMed ID: 3613938
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chinese expert consensus on blood lipid related cardiovascular residual risk control].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jul; 40(7):547-53. PubMed ID: 22943680
    [No Abstract]   [Full Text] [Related]  

  • 45. Recommendations for lipid testing and reporting by Australian pathology laboratories.
    ; Appleton CA; Caldwell G; McNeil A; Meerkin M; Sikaris K; Sullivan DR; Thomas DW; Tognarini DP
    Clin Biochem Rev; 2007 May; 28(2):32-45. PubMed ID: 17687413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipid management guidelines--2001. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand.
    ;
    Med J Aust; 2001 Nov; 175(S2):S62-85. PubMed ID: 11758552
    [No Abstract]   [Full Text] [Related]  

  • 47. Lipids in cardiovascular disease.
    Durrington PN
    Q J Med; 1993 Mar; 86(3):218-9. PubMed ID: 8483998
    [No Abstract]   [Full Text] [Related]  

  • 48. The lipid risk factor in hypertension and cardiovascular disease.
    Castelli WD
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):59S-60S. PubMed ID: 3440109
    [No Abstract]   [Full Text] [Related]  

  • 49. [The involvement of biologically active lipids in cardiovascular pharmacotherapy].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1992; 96(1-2):29-30. PubMed ID: 1410919
    [No Abstract]   [Full Text] [Related]  

  • 50. [Physico-chemical investigation of blood components using special fluorescent probes].
    Dobretsov GE
    Vestn Ross Akad Med Nauk; 2009; (10):15-9. PubMed ID: 20050071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipids and cardiovascular disease.
    Burnett JR; Hooper AJ; Hegele RA
    Pathology; 2019 Feb; 51(2):129-130. PubMed ID: 30595506
    [No Abstract]   [Full Text] [Related]  

  • 52. Antihypertensives: much ado about lipids.
    Golomb BA; Criqui MH
    Arch Intern Med; 1999 Mar; 159(6):535-7. PubMed ID: 10090108
    [No Abstract]   [Full Text] [Related]  

  • 53. National Heart Foundation Cholesterol Review. Proceedings of a round table discussion. 31 August 1993. Sydney, Australia.
    Aust N Z J Med; 1994 Feb; 24(1):81-132. PubMed ID: 7911657
    [No Abstract]   [Full Text] [Related]  

  • 54. Heaven can wait… for lipid control in very high cardiovascular risk patients.
    Mello E Silva A
    Rev Port Cardiol (Engl Ed); 2021 Sep; 40(9):649-651. PubMed ID: 34503702
    [No Abstract]   [Full Text] [Related]  

  • 55. Risk-factor levels and the MONICA study.
    Flaherty GN
    Med J Aust; 1988 May; 148(10):538. PubMed ID: 3367823
    [No Abstract]   [Full Text] [Related]  

  • 56. Investigation of lipids. What do the results really mean?
    Sullivan D
    Aust Fam Physician; 2000 Mar; 29(3):207-11. PubMed ID: 10785985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Total and regional fat and serum cardiovascular disease risk factors in lean and obese children and adolescents.
    Teixeira PJ; Sardinha LB; Going SB; Lohman TG
    Obes Res; 2001 Aug; 9(8):432-42. PubMed ID: 11500523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.